Join us for a deep dive into a series of topics specific to CGT.
The final Unbridled Excellence webinar for the year featured DHC Managing Partners—CEO Anthony Davies, COO Katy Spink, and GM of DHC Europe Rob Allen—on the topic of 2023 takeaways, 2024 predictions! Our MPs discussed their top big-picture takeaways from 2023 and their list of predictions of what-to-watch for in 2024.
Thank you for being a part of our first Regulatory Roundup LIVE along with our unparalleled team of former FDA regulators, discussing the latest and greatest regulatory news. And also, thank you to DHC Master Principal Kimberly Benton and Master Practice Expert Don Fink, as well as Senior Principal Heath Coats, Principal Kevin Whittlesey, and Practice Expert Tal Salz.
In this third episode of the DHC webinar series, we heard from DHC Principal Brent Morse in conjunction with Senior Consultant Joshua Beckett (featuring content from Senior Consultant Alicja Fiedorowicz MSc) on the topic of Phase Appropriate Analytics to Support Cell and Gene Therapy Development.